← Leaderboards
Daniel P Schuster
Washington University
$3,913,518
Attributed
$3,913,518
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $495.6K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$3,913,518 · 9
By mechanism
R01$3,370,769 · 3
P01$308,594 · 1
R21$176,147 · 1
M01$58,008 · 4
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Timothy J Eberlein$71,591,509
- Vijay Sharma$15,781,488
- Douglas Robert Spitz$16,909,444
- Daniel A Low$5,513,107
- Tammie Lee Smith Benzinger$27,265,928
Research focus
Positron Emission TomographyHuman SubjectClinical ResearchNeutrophilLung InjuryDogsAdult Respiratory Distress SyndromeBioimaging /Biomedical ImagingRespiratory Disorder DiagnosisProstaglandin Endoperoxide SynthasePulmonary EdemaDisease /Disorder ModelPulmonary RespirationMethod DevelopmentRadiotracerThromboxanesProstacyclinsEicosanoid MetabolismPhospholipase A2Noninvasive DiagnosisPlatelet Activating FactorInflammationPulmonary CirculationTumor Necrosis Factor Alpha
Grant awards (19)
Pulmonary Transgene Expression Imaging with PET$444,947
R01 · FY2007 · HL · contact PI
FDG-PET IMAGING AS A MARKER OF ANTI-INFLAMMATORY DRUG EFFECTS$12,065
M01 · FY2007 · RR · contact PI
EFFECTS OF LOVASTATIN (MEVACOR) IN CYSTIC FIBROSIS PATIENTS$1,491
M01 · FY2007 · RR · contact PI
Pulmonary Transgene Expression Imaging with PET$449,168
R01 · FY2006 · HL · contact PI
NEUTROPHIL GLUCOSE DURING LUNG INJURY USING FLURODEOXYGLUCOSE$3,748
M01 · FY2006 · RR · contact PI
Pulmonary Transgene Expression Imaging with PET$476,338
R01 · FY2005 · HL
NEUTROPHIL GLUCOSE DURING LUNG INJURY USING FLURODEOXYGLUCOSE$18,485
M01 · FY2005 · RR
QUANTIFICATION OF PULMONARY NEUTROPHIL ACTIVITY IN CYSTIC FIBROSIS$822
M01 · FY2005 · RR
Neutrophil Specific Transgene Expression Imaging$176,147
R21 · FY2004 · EB
Neutrophil Glucose During Lung Injury using Fluorodeoxyg$21,078
M01 · FY2004 · RR
Quantification of Pulmonary Neutrophil Activity in Cystic Fibrosis$319
M01 · FY2004 · RR
LUNG PERFUSION BY POSITRON EMISSSION TOMOGRAPHY$412,596
R01 · FY2003 · HL
LUNG PERFUSION BY POSITRON EMISSSION TOMOGRAPHY$403,225
R01 · FY2002 · HL
ROLE OF ACE IN PULMONARY HYPERTENSION$0
P01 · FY2002 · HL
LUNG PERFUSION BY POSITRON EMISSSION TOMOGRAPHY$398,871
R01 · FY2001 · HL
ROLE OF ACE IN PULMONARY HYPERTENSION$0
P01 · FY2001 · HL
LUNG PERFUSION BY POSITRON EMISSSION TOMOGRAPHY$421,420
R01 · FY2000 · HL
RELATIONSHIP OF PERMEABILITY (BY PET) TO LUNG INJURY$364,204
R01 · FY2000 · HL
ROLE OF ACE IN PULMONARY HYPERTENSION$308,594
P01 · FY2000 · HL